Page last updated: 2024-08-21

fluorobenzenes and Heart Failure, Systolic

fluorobenzenes has been researched along with Heart Failure, Systolic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aukrust, P; Block, D; Gullestad, L; Kjekshus, J; McMurray, JJ; Nymo, SH; Ueland, T; Wienhues-Thelen, UH; Wikstrand, J; Zaugg, C1
Cas, LD; Maggioni, AP; Metra, M; Nodari, S; Zacá, V1
Dunselman, P; Grande, P; Gullestad, L; Hjalmarson, A; Hradec, J; Kamenský, G; Kjekshus, J; Korewicki, J; Kuusi, T; Lindberg, M; Mach, F; McMurray, JJ; Ranjith, N; Waagstein, F; Wedel, H; Wikstrand, J1
Adourian, A; Aukrust, P; Böhm, M; Cleland, JG; Gullestad, L; Hulthe, J; Kjekshus, J; Komajda, M; McMurray, JJ; Muntendam, P; Nymo, SH; Ueland, T; van Veldhuisen, DJ; Wikstrand, J1
Wollert, KC1
Aukrust, P; Gullestad, L; Hulthe, J; Kjekshus, J; McMurray, JJ; Muntendam, P; Nymo, SH; Ueland, T; Wikstrand, J1
Jackson, G1

Trials

3 trial(s) available for fluorobenzenes and Heart Failure, Systolic

ArticleYear
Predictive value of endostatin in chronic heart failure patients with poor kidney function.
    Cardiology, 2015, Volume: 130, Issue:1

    Topics: Aged; Aged, 80 and over; C-Reactive Protein; Endostatins; Female; Fluorobenzenes; Glomerular Filtration Rate; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoenzyme Techniques; Kidney Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2015
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    European heart journal, 2012, Volume: 33, Issue:18

    Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fluorobenzenes; Galectin 3; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Lipid Metabolism; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides; Treatment Outcome

2012
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    American heart journal, 2012, Volume: 164, Issue:6

    Topics: Aged; Aged, 80 and over; Biomarkers; Female; Fluorobenzenes; Galectin 3; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Prognosis; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides

2012

Other Studies

4 other study(ies) available for fluorobenzenes and Heart Failure, Systolic

ArticleYear
[The CORONA study].
    Giornale italiano di cardiologia (2006), 2008, Volume: 9, Issue:4

    Topics: Age Factors; Aged; Aged, 80 and over; Cholesterol, LDL; Fluorobenzenes; Follow-Up Studies; Heart Failure, Systolic; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Prospective Studies; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome

2008
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
    Circulation, 2009, Dec-01, Volume: 120, Issue:22

    Topics: Aged; Aged, 80 and over; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Female; Fluorobenzenes; Heart Failure, Systolic; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Triglycerides

2009
Tailored therapy for heart failure: the role of biomarkers.
    European heart journal, 2012, Volume: 33, Issue:18

    Topics: Female; Fluorobenzenes; Galectin 3; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2012
CORONA--rosuvastatin in older patients with systolic heart failure.
    International journal of clinical practice, 2008, Volume: 62, Issue:1

    Topics: Fluorobenzenes; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides

2008